BCM
BOLD

Bridgeway Capital Management’s Boundless Bio BOLD Stock Holding History

Bridgeway Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.5K Hold
50,500
– – ﹤0.01% 1182
2025
Q4 		$60.6K Hold
50,500
– – ﹤0.01% 1171
2025
Q3 		$62.1K Hold
50,500
– – ﹤0.01% 1152
2025
Q2 		$51K Buy
+50,500
New +$67.1K ﹤0.01% 1136
2025
Q1 		– Sell
-50,000
Closed -$145K – 1261
2024
Q4 		$145K Hold
50,000
– – ﹤0.01% 1058
2024
Q3 		$174K Buy
+50,000
New +$181K ﹤0.01% 1095

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Bridgeway Capital Management's BOLD Position: Q1 2026 in Review

Bridgeway Capital Management held its Boundless Bio (BOLD) position steady in Q1 2026 at 50,500 shares worth $55.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Bridgeway Capital Management first reported a position in BOLD in Q3 2024 and has held it in 6 quarters since. The position peaked at $174K in Q3 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Bridgeway Capital Management held 50,500 shares of Boundless Bio worth $55.5K as of Q1 2026.
  • Bridgeway Capital Management left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1182 holding.
  • Bridgeway Capital Management first reported a position in Boundless Bio in Q3 2024 and has held it in 6 quarters since.
  • Bridgeway Capital Management's Boundless Bio position peaked at $174K in Q3 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.